185913-28-4

Basic information

• Product Name: 2-(3-fluorophenoxy)tetrahydro-2H-pyran
• Synonyms: 2-(3-fluorophenoxy)tetrahydro-2H-pyran
• CAS NO: 185913-28-4
• Molecular Weight: 196.221
• Mol File: 185913-28-4.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2-(3-fluorophenoxy)tetrahydro-2H-pyran(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-fluorophenoxy)tetrahydro-2H-pyran(185913-28-4)
• EPA Substance Registry System: 2-(3-fluorophenoxy)tetrahydro-2H-pyran(185913-28-4)

Safety Data

• Hazardous Substances Data: 185913-28-4(Hazardous Substances Data)

Upstream product

• 110-87-2 3,4-dihydro-2H-pyran 
• 372-20-3 3-fluorophenol 

Downstream Products

• 1256345-60-4 (2-fluoro-6-hydroxy-phenyl)boronic acid 
• 76-80-2 (±)-12a-epi-tephrosin 
• 76-80-2 (+/-)-tephrosin 
• 207597-97-5 12aα-hydroxydeguelin 
• 76-80-2 tephrosin 
• 522-17-8 (-)-deguelin 
• 372-20-3 3-fluorophenol 
• 1316276-97-7 C₂₂H₂₄F₂O₄ 
• 185913-30-8 2,2′,2″-phosphinetriyltris(3-fluorophenol) 
• 199388-06-2 4-(3-Fluoro-2-formyl-phenoxymethyl)-benzoic acid methyl ester 
• 38226-10-7 2-fluoro-6-hydroxybenzaldehyde 
• 199388-02-8 2-fluoro-6-((tetrahydro-2H-pyran-2-yl)oxy)benzaldehyde 
• 185913-29-5 tris[2-fluoro-6-(tetrahydro-2H-pyran-2-yloxy)phenyl]phosphine 

Relevant articles and documents

Method for synthesizing 2-fluoro-6-hydroxyphenylboronic acid

The invention belongs to the field of synthesis of pharmaceutical compounds, and provides a method for synthesizing 2-fluoro-6-hydroxyphenylboronic acid. The method comprises the following two steps:1) synthesizing an intermediate: reacting 3-fluorophenol

Foiling Normal Patterns of Crystallization by Design. Polymorphism of Phosphangulene Chalcogenides

Phosphangulene (1) has a well-defined hexacyclic structure with a distinctive conical shape and an electron-rich aromatic surface. Molecules of phosphangulene are disposed to crystallize in parallel π-stacks. This preference can be thwarted by adding a si

C- ARYL GLYCOSID DERIVATIVES, PHARMACEUTICAL COMPOSITION, PREPARATION PROCESS AND USES THEREOF

This invention relates to a kind of C-aryl glycoside derivatives, its pharmaceutical compositions, preparation methods, and uses thereof. The preparation method comprises: method 1: in a solvent, deprotecting the acetyl protecting groups of compound 1-f in the presence of a base; method 2: 1) compound 2-g reacts with via Mitsunobu reaction; 2) deprotecting the acetyl protecting groups of compound 2-f obtained from step 1; method 3: 1) compound 2-g reacts with via nucleophilic substitution reaction; 2) deprotecting the acetyl protecting groups of compound 3-f obtained from step 1. The pharmaceutical composition comprises a kind of C-aryl glycoside derivatives; it's pharmaceutically acceptable salts and/or prodrugs thereof and excipient thereof. This invention further relates to a kind of C-aryl glycoside derivatives, it's pharmaceutically acceptable salts or pharmaceutical compositions thereof for the use in preparation of a SGLT inhibitor. The C-aryl glycoside derivatives of this invention provides a new direction for the study of SGLT inhibitors.